Neuroscience, the study of brain development, function, plasticity and disease, offers perhaps the most complex challenge in all of biology, relating the structure and output of genomes to the neural processes that ultimately register as thought, memory, emotion, and mood. The complexity of the biological mechanisms involved is mirrored by the interdisciplinary training required of neurobiologists, where years of postgraduate research and education are now needed to efficiently and competitively embrace the opportunities of brain science in a genomic age. Brain diseases, many with complex genetic underpinnings, constitute a great burden on individuals, families, care-givers and society, dictating novel training mechanisms to increase the sophistication of both basic and clinical neuroscientists. Multiple genomes have been sequenced, including model systems of organisms where simpler nervous systems and powerful genetics offer an accelerated pace of discovery. New mouse and human genomic information is available that can lead both to important new disease models, to diagnostic insights and to targeted therapies of brain disorders. At the same time, """"""""topdown"""""""" approaches in neurobiology have gained momentum, allowing a greater sophistication in behavioral phenotyping and direct visualization, via PET, SPECT and fMRI, of functional specializations in the living brain. The next generation of neuroscientists will need to be able to tap genomic sciences but at the same time recognize and investigate more complex neurobiologic processes that ultimately support brain disorders. In this context, we propose the Training Program in Neurogenomics. Our program organizes the postdoctoral training efforts of 35 senior and 16 junior faculty in basic and clinical departments at Vanderbilt and Meharry Medical College through the Vanderbilt Center for Molecular Neuroscience. Our program provides for formal research training and didactic instruction, as well as seminars and technical workshops at the interface of neuroscience and genomic research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Institutional National Research Service Award (T32)
Project #
5T32MH065215-05
Application #
7115370
Study Section
Special Emphasis Panel (ZMH1-BRB-P (01))
Program Officer
Desmond, Nancy L
Project Start
2002-07-15
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2008-06-30
Support Year
5
Fiscal Year
2006
Total Cost
$281,369
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Stewart, Adele; Davis, Gwynne L; Gresch, Paul J et al. (2018) Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. Neuropsychopharmacology :
Morgan, Amanda J; Kingsley, Philip J; Mitchener, Michelle M et al. (2018) Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain. ACS Chem Neurosci 9:1552-1559
Fisher, Nicole M; Gogliotti, Rocco G; Vermudez, Sheryl Anne D et al. (2018) Genetic Reduction or Negative Modulation of mGlu7 Does Not Impact Anxiety and Fear Learning Phenotypes in a Mouse Model of MECP2 Duplication Syndrome. ACS Chem Neurosci 9:2210-2217
Stansley, Branden J; Fisher, Nicole M; Gogliotti, Rocco G et al. (2018) Contextual Fear Extinction Induces Hippocampal Metaplasticity Mediated by Metabotropic Glutamate Receptor 5. Cereb Cortex 28:4291-4304
Yohn, Samantha E; Conn, P Jeffrey (2018) Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia. Neuropharmacology 136:438-448
Vranjkovic, Oliver; Winkler, Garrett; Winder, Danny G (2018) Ketamine administration during a critical period after forced ethanol abstinence inhibits the development of time-dependent affective disturbances. Neuropsychopharmacology 43:1915-1923
Robinson, Sarah B; Hardaway, J Andrew; Hardie, Shannon L et al. (2017) Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization. Mol Cell Neurosci 78:41-51
Rogers, Tiffany D; Anacker, Allison M J; Kerr, Travis M et al. (2017) Effects of a social stimulus on gene expression in a mouse model of fragile X syndrome. Mol Autism 8:30
Abe, Masahito; Seto, Mabel; Gogliotti, Rocco G et al. (2017) Discovery of VU6005649, a CNS Penetrant mGlu7/8 Receptor PAM Derived from a Series of Pyrazolo[1,5-a]pyrimidines. ACS Med Chem Lett 8:1110-1115
Gogliotti, Rocco G; Senter, Rebecca K; Fisher, Nicole M et al. (2017) mGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome. Sci Transl Med 9:

Showing the most recent 10 out of 162 publications